MANTIS

LightPath Technologies, Inc. CEO, Sam Rubin, Discusses Innovative Applications For its Proprietary Black Diamond(TM) Glass Lenses with The Stock Day Podcast

Retrieved on: 
Thursday, January 5, 2023

"I came to LightPath after spending my whole career in the optics and photonics industry," said Rubin.

Key Points: 
  • "I came to LightPath after spending my whole career in the optics and photonics industry," said Rubin.
  • "I chose LightPath because I felt as though it was under utilized in terms of its capabilities and technologies," he shared.
  • "How do you plan on leveraging your proprietary Black Diamondâ„¢("BD6") chalcogenide-based glass lenses to induce customers to partner with you on higher value projects?"
  • Rubin then discussed the Company's Black Diamondâ„¢ glass, which allows designers to utilize a variety of optical applications while minimizing the use of crystal glass.

Draper Advances Growth-Adaptive Pediatric Heart Valve with Sutureless Adhesive

Retrieved on: 
Tuesday, September 27, 2022

CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire-PRWeb/ -- Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before adulthood to replace prosthetics as they grow. Mortality and morbidity remain high, in part because there is no clinical standard for valve replacement in children under 5 years of age.

Key Points: 
  • A sutureless adhesive applied to a pediatric heart valve stent may save surgeons time during operations and simplify the production process for device manufacturers.
  • CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire-PRWeb/ -- Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before adulthood to replace prosthetics as they grow.
  • To address this need, Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valvethe first heart valve that can grow with the patient.
  • The LEAP heart valve will incorporate the microstructures we are developing to integrate mechanically with the bioprosthetic valve tissue without the need for sutures."

MPCH Labs Completes $40M Series A Raise led by Liberty City Ventures ahead of the launch of Fraction

Retrieved on: 
Tuesday, September 27, 2022

NEW YORK, Sept. 27, 2022 /PRNewswire-PRWeb/ -- MPCH Labs, Inc. (MPCH.io), a tech venture studio developing the next generation of Multi-Party Computation (MPC) technology, announces the completion of its $40M Series A funding round. The funding round was led by Liberty City Ventures and also includes QCP Capital, Mantis VC, Human Capital, Global Coin Research, LedgerPrime, Finality Capital, Oak HC FT, Polygon Studios, Quantstamp, and Animoca Brands. MPCH was incubated at Liberty City Ventures (LCV). LCV has a history of co-founding and incubating prominent infrastructure companies in the blockchain sector. With the completion of the Series A round, this brings total funding to-date to $50M.

Key Points: 
  • MPCH was incubated at Liberty City Ventures (LCV).
  • MPCH Labs was born out of the belief that MPC technology is the foundation for a new world of trade, technology and commerce.
  • The Series A funding will support the continued development and deployment of MPCH Labs' first product, Fraction , which will launch in Q4 of this year.
  • Fraction, a creation of MPCH Labs, is a fully configurable operating platform that enables institutions to safeguard their own digital assets in a secure and decentralized way.